We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SNPHY market cap is 3.68B. The company's latest EPS is JPY -39.8600 and P/E is -0.25.
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 234.46B | 241.95B | 265.61B | 266.81B | 282.56B |
Operating Income | 41.55B | 33.55B | 12.66B | 33.87B | -4.9B |
Net Income | 31.94B | 21.71B | 6.65B | 27.19B | -14.98B |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 391.19B | 408.77B | 402.35B | 459.98B | 421.18B |
Total Liabilities | 98.61B | 106.21B | 95.3B | 123.13B | 127.88B |
Total Equity | 292.57B | 302.56B | 307.05B | 336.84B | 293.3B |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 32.89B | 39.95B | 38.81B | 46.04B | 37.15B |
Investing | -2.94B | -5.17B | -53.36B | -35.17B | -26.78B |
Financing | -28.11B | -12.73B | -16.69B | 5.56B | -37.22B |
Market Cap | 3.68B |
Price to Earnings Ratio | -0.25 |
Price to Sales Ratio | 0.01 |
Price to Cash Ratio | 0.07 |
Price to Book Ratio | 0.01 |
Dividend Yield | - |
Shares Outstanding | 375.89M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.63 (6.26%) |
Company Name | Santen Pharmaceutical Company (PK) |
Address |
4-20 ofuka town higashiosaka, osaka 533-8651 |
Website | https://www.santen.co.jp |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions